| 1 |
29174531 | Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies. | 2018 Apr |
1 |
| 2 |
22050051 | Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. | 2012 Nov |
1 |
| 3 |
21421022 | Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze. | 2011 May 9 |
3 |
| 4 |
21562484 | Blockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairment. | 2011 Aug |
1 |
| 5 |
22207908 | The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design. | 2011 Dec |
1 |
| 6 |
17928105 | An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. | 2008 Mar-Apr |
1 |
| 7 |
18054209 | Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients. | 2008 Feb |
1 |
| 8 |
18194152 | Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. | 2008 Jun |
1 |
| 9 |
17200914 | [40 years beta-adrenoceptor blockers in psychiatry]. | 2007 Apr |
1 |
| 10 |
17804228 | Indoloxypropanolamine analogues as 5-HT(1A) receptor antagonists. | 2007 Oct 15 |
2 |
| 11 |
16475955 | Pindolol augmentation of antidepressant response. | 2006 Feb |
5 |
| 12 |
15648095 | Pindolol augmentation of selective serotonin reuptake inhibitors: accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression. | 2005 Apr |
1 |
| 13 |
16307210 | A mathematical model for paroxetine antidepressant effect time course and its interaction with pindolol. | 2005 Dec |
1 |
| 14 |
14720318 | An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain. | 2004 Mar |
4 |
| 15 |
15006431 | Once-daily high-dose pindolol for SSRI-refractory depression. | 2004 Feb 15 |
2 |
| 16 |
15127080 | Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression? | 2004 Sep |
3 |
| 17 |
12536263 | Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. | 2003 Mar |
1 |
| 18 |
12589521 | EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans. | 2003 Mar |
4 |
| 19 |
12880941 | Pindolol and the acceleration of the antidepressant response. | 2003 Aug |
1 |
| 20 |
14615704 | [Interest of the use of pindolol in the treatment of depression: review]. | 2003 Jul-Aug |
1 |
| 21 |
12166089 | [Effect of (+/-)-pindolol on the central 5-HT1A receptor by the use of in vivo microdialysis and hippocampal slice preparations]. | 2002 Jun |
8 |
| 22 |
11077069 | Modulation of 5-HT(1A) receptor activation by its interaction with wild-type and mutant g(alphai3) proteins. | 2001 |
1 |
| 23 |
11166513 | Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans. | 2001 Mar |
1 |
| 24 |
11199945 | Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. | 2001 Feb |
3 |
| 25 |
11236069 | Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study. | 2001 Mar |
1 |
| 26 |
11330332 | Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a. | 2001 Apr |
4 |
| 27 |
11444761 | Pharmacology of rapid-onset antidepressant treatment strategies. | 2001 |
1 |
| 28 |
11457419 | Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? | 2001 Jul 1 |
1 |
| 29 |
11713611 | Quantifying the 5-HT1A agonist action of buspirone in man. | 2001 Nov |
1 |
| 30 |
11729033 | Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. | 2001 Dec |
1 |
| 31 |
10823340 | Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep. | 2000 Apr 14 |
1 |
| 32 |
10862804 | 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus. | 2000 Jun 15 |
4 |
| 33 |
10942852 | beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy. | 2000 Sep |
4 |
| 34 |
10962261 | Positron emission tomography study of pindolol occupancy of 5-HT(1A) receptors in humans: preliminary analyses. | 2000 Jul |
6 |
| 35 |
11022403 | Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats. | 2000 Sep |
3 |
| 36 |
11063976 | Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations. | 2000 Oct 15 |
1 |
| 37 |
11063979 | Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies. | 2000 Oct 15 |
4 |
| 38 |
11185947 | Pindolol augmentation of antidepressants: a review and rationale. | 2000 Feb |
1 |
| 39 |
11379796 | The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency? | 2000 Jun |
2 |
| 40 |
10100214 | Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor. | 1999 Feb |
1 |
| 41 |
10369467 | Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. | 1999 May |
2 |
| 42 |
10400249 | Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. | 1999 May 21 |
1 |
| 43 |
10435400 | Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography. | 1999 Jun |
3 |
| 44 |
10459173 | Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. | 1999 Oct |
5 |
| 45 |
16160947 | 5-HT1A receptor antagonists as putative adjuvants to antidepressants: preclinical and clinical evidence. | 1999 Feb |
1 |
| 46 |
9536453 | Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors. | 1998 May |
3 |
| 47 |
9635544 | The use of pindolol to potentiate antidepressant medication. | 1998 |
1 |
| 48 |
9778659 | Effect of ergotamine on serotonin-mediated responses in the rodent and human brain. | 1998 Nov |
1 |
| 49 |
9873746 | Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors. | 1998 Dec 1 |
1 |
| 50 |
9920534 | Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer. | 1998 Jul |
1 |